World Journal of AIDS
Vol.2 No.3(2012), Paper ID 22606, 7
pages
DOI:10.4236/wja.2012.23032
Trizivir (Abacavir/Lamivudine/Zidovudine) plus Lopinavir/Ritonavir Induction Therapy Followed by Trizivir-Alone Maintenance for HIV-1-Infected Patients: A 96-Week Pilot Treatment Simplification Study
Joseph C. Gathe, Dean T. Martin, M. Keith Rawlings, Benjamin Daquioag, John E. Fuchs, Vanessa C. Williams, Katrina L. Oie, Gary E. Pakes
Therapeutic Concepts P.A., Houston, USA
Cigna Healthcare Corp., Phoenix, USA
Peabody Clinic, Dallas, USA
Therapeutic Concepts P.A., Houston, USA
Glaxo-SmithKline, Research Triangle Park, Durham, USA
Glaxo-SmithKline, Research Triangle Park, Durham, USA
Glaxo-SmithKline, Research Triangle Park, Durham, USA
Glaxo-SmithKline, Research Triangle Park, Durham, USA
Copyright © 2012 Joseph C. Gathe, Dean T. Martin, M. Keith Rawlings, Benjamin Daquioag, John E. Fuchs, Vanessa C. Williams, Katrina L. Oie, Gary E. Pakes et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
J. C. Gathe, D. T. Martin, M. Keith Rawlings, B. Daquioag, J. E. Fuchs, V. C. Williams, K. L. Oie and G. E. Pakes, "Trizivir (Abacavir/Lamivudine/Zidovudine) plus Lopinavir/Ritonavir Induction Therapy Followed by Trizivir-Alone Maintenance for HIV-1-Infected Patients: A 96-Week Pilot Treatment Simplification Study,"
World Journal of AIDS, Vol. 2 No. 3, 2012, pp. 245-251. doi:
10.4236/wja.2012.23032.